Author

C. Nie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1 Research Focus:protein folding & dynamics· 1 Assay:structural biology· 1

Frequent Co-Authors

A. L. BURRELL· 1 shared B. B. Kaufer· 1 shared D. Fernandez-Justel· 1 shared I.-M. Wang· 1 shared J. C. Simonet· 1 shared J. M. Kollman· 1 shared J. Mandl· 1 shared J. Quispe· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. L. BURRELL

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

IMPDH1 retinal variants control filament architecture to tune allosteric regulation

A. L. BURRELL, C. Nie, M. Said, J. C. Simonet, D. Fernandez-Justel, M. C. Johnson, J. Quispe, R. M. Buey, J. R. Peterson, J. M. Kollman

The paper shows IMPDH1 retinal variants form different filaments that affect GTP regulation, with disease mutations disrupting or not affecting this regulation.

bioRxiv · Aug 3, 2021Biochemistry

Responding kinetic of B-cell receptor repertoire to the Toll-like receptor 7/8 stimulation in non-human primates

S. Wang, J. Mandl, M. Feinberg, M. Citron, N. K. Saksena, L. Luo, Z. Li, Y. Zhu, T. Li, C. Nie, X. Zhang, Y. Liu, X. Liu, I.-M. Wang, W. Zhang

This study examines the kinetic response of B-cell receptor (BCR) repertoire diversity and lineage expansion in non-human primates after TLR7/8 stimulation, finding that TLR7/8 selectively expands high-mutation, low-frequency IgKL lineages.

bioRxiv · Mar 15, 2021 · PreprintImmunology

In vitro efficacy of Artemisia extracts against SARS-CoV-2

C. Nie, J. Trimpert, S. Moon, R. Haag, K. Gilmore, B. B. Kaufer, P. H. Seeberger

This study evaluates the in vitro antiviral efficacy of Artemisia extracts and a herbal drink against SARS-CoV-2 and FCoV, showing inhibition at non-toxic concentrations.

bioRxiv · Feb 14, 2021Pharmacology & Toxicology